Glenmark Life Sciences Q4 Results
- BSE: 543322
- NSE: GLS
- ISIN: INE03Q201024
- Sector: Biotechnology & Drugs
BSE
1,097.55
48.65 (4.64%)
48.65 (4.64%)Volume13.13 K
Updated: Mon 25 Nov, 2024 | 15:29:08
NSE
1,092.6547.00 (4.49%)
47.00 (4.49%)Volume2.00 L
Updated: Mon 25 Nov, 2024 | 15:42:42
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Glenmark Life Sciences Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 24 | Dec 23 | QoQ Comp |
|---|---|---|---|
| Total Revenue | 536.60 | 572.80 | -% |
| Selling/ General/ Admin Expenses Total | 72.26 | 71.05 | -% |
| Depreciation/ Amortization | 14.53 | 13.18 | -% |
| Other Operating Expenses Total | 84.20 | 87.00 | -% |
| Total Operating Expense | 409.69 | 413.43 | -% |
| Operating Income | 126.91 | 159.38 | -% |
| Net Income Before Taxes | 129.68 | 160.68 | -% |
| Net Income | 97.94 | 118.77 | -% |
| Diluted Normalized EPS | 7.97 | 9.67 | -% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
- Markets
01NTPC Green Energy IPO allotment date likely today. GMP, how to check status online
2 min read07:58 AM IST - Markets
02Buy or sell: Sumeet Bagadia recommends three stocks to buy on Monday — Nov 25
4 min read06:15 AM IST - Markets
03Enviro Infra Engineers IPO day 2: GMP jumps; subscription status, review, apply or not?
3 min read03:07 PM IST